logo
Send Message
ANHUI BBCA PHARMACEUTICAL CO.,LTD
ANHUI BBCA PHARMACEUTICAL CO.,LTD
products
Home /

products

Oral Cardiovascular Drug GMP Certified Naftopidil Tablets 12.5mg/Day

Product Details

Place of Origin: CHINA

Brand Name: BBCA

Certification: GMP

Model Number: BBCA201804093

Payment & Shipping Terms

Minimum Order Quantity: 1000000 pcs

Price: Negotiated

Delivery Time: 25 DAYS AFTER PAYMENT

Payment Terms: L/C, T/T, , MoneyGram, L/C, T/T, , MoneyGram

Supply Ability: 10000000000 PCS PER YEAR

Get Best Price
Contact Now
Specifications
Highlight:

cilnidipine tablets

,

naftopidil tablets

Description
Oral Cardiovascular Drug GMP Certified Naftopidil Tablets 12.5mg/Day

Oral Cardiovascular Drug GMP Certified Naftopidil Tablets 12.5mg/Day

 

[INDICATIONS]
It is used to relieve the symptoms of urinary obstruction caused by benign prostatic hyperplasia (BPH).
[USAGE AND DOSAGE]
Oral. Usually, the initial dosage of adult is 25mg (1 tablets), once a day, taken before bedtime. The dose can be adjusted appropriately with the clinical effect. The maximum dose may not exceed 75mg (3 tablets) per day. Elderly patients should start from low dose (12.5mg/day), and care for them.

[ADVERSE REACTION]
dizziness, standing vertigo, head weight, headache, tinnitus, constipation, stomach discomfort, edema, chills, AST elevation and ALT elevation.
[CONTRAINDICATION]
It is forbidden for someone has a history of allergy .

[DRUG INTERACTION]
This product has synergistic antihypertensive effect with the combination of diuretics and antihypertensive drugs, and should be reduced when combined.
[DRUG OVERDOSE]
There are no reports of overdose of the drug at present. If you take too much, you should take symptomatic treatment.

Send your inquiry
Please send us your request and we will reply to you as soon as possible.
Send